Study of activation cross sections of deuteron-induced reactions on erbium for applications

摘要

The use of compounds and biomolecules labeled with radionuclides of rare-earth elements is a fast growing field in therapeutic nuclear medicine. These radionuclides are currently produced by (n) caption in a nuclear reactor, but to obtain high specific activity or end products at the no carrier added level, usually alternative production routes utilizing charged particle-induced processes are required.